Showing results (1421-1430 of 4,229) with videos related to

Sort By:
Pageof 423
Discover Oncology|February 18, 2026
Higher frequency of circulating regulatory T cells is associated with poor outcomes in patients with colorectal cancerYan Lu, Haoyang Guo, Taotao Guo, et al.
Discover Oncology|May 26, 2023
NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathwayDong Guo, Weinan Yao, Xingyu Du, et al.
Discover Oncology|January 31, 2023
Machine learning to predict overall short-term mortality in cutaneous melanomaC Cozzolino, A Buja, M Rugge, et al.
Discover Oncology|June 16, 2026
The adenosine A2A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implicationsDevangini Sharma, Sandeep Sisodiya, Showket Hussain, et al.
Discover Oncology|March 7, 2023
Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective studyAzumi Kaneoka, Satoka Hashimoto Fujimoto, Kaoru Tamura, et al.
Discover Oncology|February 16, 2023
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancerChen Liu, Shengming Deng, Zhiwen Xiao, et al.
Discover Oncology|March 17, 2023
Radiotherapy combined with anti-CEACAM1 immunotherapy to induce survival advantage in gliomaJinhu Li, Yi Chen, Yimin Fan, et al.
Discover Oncology|February 25, 2023
Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell lineHeidrun Weidemann, Daniel Feger, Jan E Ehlert, et al.
Discover Oncology|February 17, 2026
Prostate cancer associated 3 (PCA3) is a potential indicator of the pathological grades of prostate cancerYangyang Guo, Wenlong Chen, Jing Zhu, et al.
Discover Oncology|February 15, 2026
Characterization of tumour microenvironment in thymic epithelial tumours of different histological subtypesWei Liu, Qin Yan, Qi-Nian Wu, et al.
Pageof 423